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ABSTRACT
Objective: The current research focuses on solubility enhancement of poorly water-soluble drug telmisartan, using novel superdisintegrants such 
as Entada scandens seed starch and Poloxamer-188. Starches yielded from plants are pharmaceutically useful as binders, diluents, disintegrants, and 
lubricants.
Methods: Starches were extracted from E. scandens seed powder using alkali method (sodium hydroxide at 0.1%, 0.25%, and 0.5% concentrations) 
and water. These starches were subjected for the evaluation of various physicochemical properties and phytochemical tests.
Results: The phytochemical tests revealed the presence of only starch in all the extracts. Of all the starches, the starch prepared from 0.5% sodium 
hydroxide (ESS4) showed best physicochemical properties. Solid dispersions were prepared using telmisartan, poloxamer-188, and starch (ESS4) in various 
concentrations using fusion technique. Various pre-formulation parameters were evaluated. From in vitro dissolution studies, it was observed that the solid 
dispersion formulation TP7 containing telmisartan and poloxamer-188 in 1:4 ratios showed better dissolution rate. Solid dispersion TPS7 containing TP7 
formulation and 15% w/w of alkali extracted starch showed faster disintegration and enhanced dissolution rate than the solid dispersions prepared alone 
with poloxamer-188. Fourier transform infrared spectroscopy and differential scanning calorimetric studies for optimized formulations revealed that there 
were no major interactions between the drug and excipients. X-ray diffraction studies revealed the crystalline and amorphous nature of formulations.
Conclusion: Thus, the solid dispersions prepared using E. scandens seed starch revealed the superdisintegrant property of starch.
Keywords: Entada scandens, Solid dispersions, Telmisartan, Poloxamer-188.
INTRODUCTION
Oral palatability of a dosage form is comfortable and familiar means 
of taking medication, according to the patient [1]. Although it is much 
preferred, limited drug absorption which results in poor bioavailability 
is a major issue that can be observed while delivering an active agent 
through oral route. This may be attributed to various factors such as poor 
aqueous solubility or membrane permeability of the drug molecule. In the 
Biopharmaceutical Classification System (BCS), drugs with low aqueous 
solubility and high membrane permeability are categorized as Class II 
drugs. One of such drugs which fall under this category is telmisartan. 
One of the approaches which enhance the dissolution rate of poorly 
water-soluble drugs is “solid dispersions. Solid dispersions are a group 
of solid products consisting of a hydrophilic matrix and a hydrophobic 
drug [2]. As they increase the dissolution rate of drug at the absorption 
site, there is a gradual increase in the bioavailability too [3]. The solid 
dispersions were prepared using various techniques such as physical 
mixing, solvent evaporation, kneading, and fusion. Usage of certain 
superdisintegrants such as sodium starch glycolate, croscarmellose, 
and polyvinylpyrrolidine provides instantaneous degradation of the 
formulation. They are effective even at low concentrations. They 
were added to the formulation to promote the breakup of “slugs” into 
smaller fragments in an aqueous environment, thereby increasing the 
available surface area and promoting a more rapid release of the drug 
substance. They promote moisture penetration and dispersion [4]. 
Solid dispersions are investigated in many studies because they are 
highly versatile in their application. They can form the basis of products 
applied for various routes of administration and for various dosage 
forms, including the most popular dosage form, the tablet. Therefore, 
solid dispersion technologies are particularly promising for improving 
the oral absorption and bioavailability of BCS Class II drugs.
Natural superdisintegrants are preferable over synthetic forms, due to a 
wide range of availability, cost-effective, non-irritating, and non-toxic in 
nature. Various plant gums and mucilages also have superdisintegrant 
property [5]. These are mainly useful in improving the water solubility 
of BCS Class II drugs. These are the drugs with low solubility and 
high permeability properties. Past studies revealed the applications 
of components from plants like Ocimum tenuiflorum, Plantago ovata 
mucilage, Aloe vera mucilage, mucilage of Hibiscus rosa sinensis, and 
Lotus bean gum as superdisintegrants in formulating several BCS 
class II drugs.
In the present study, an attempt was made to extract starch from 
Entada scandens seed powder and to use it as superdisintegrant for 
preparing solid dispersions. The seed starch obtained from E. scandens 
possesses superdisintegrant property. E. scandens belonging to the 
family Fabaceae grows in evergreen tropical climates of India, Africa, 
and Australia. Fruits grow up to 6-m length with many seeds. Their 
seeds have a thick and durable seed coat which is brownish in color, 
which allows them to survive lengthy periods of immersion in seawater. 
It contains a fleshy white cotyledon [6]. They are rich in starch contents.
Telmisartan which is an antihypertensive agent is selected as the drug 
of choice for the present study. It belongs to the angiotensin receptor 
blocker class which mainly acts by inhibiting the angiotensin-II 
receptor. This prevents vasoconstriction and thereby reduces blood 
pressure. The absolute bioavailability of telmisartan depends on 
dosage. The drug is highly bound to plasma proteins (>99.5%). It has 
an approximate terminal elimination half-life of 24 h [7]. Based on 
pharmacokinetic and pharmacodynamic parameters, telmisartan is 
selected as the drug of choice for the present study.
© 2018 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2018.v11i9.28422
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The main aim of the current study was to extract starch from 
E. scandens seed powder and to formulate solid dispersions using 
it. Telmisartan solid dispersions were formulated with different 
concentrations of superdisintegrants using fusion technique. A novel 
formulation was prepared using the best formulation with maximum 




Telmisartan was a gift sample from Mylan Laboratories Ltd. (Hyderabad, 
India). Sodium hydroxide was procured from S.D Fine Chem. Ltd. 
(Mumbai, India). Potassium dihydrogen orthophosphate and sodium 
lauryl sulfate were procured from Qualigens Fine Chemicals (Mumbai, 
India). Poloxamer-188 was a gift sample from M/s Pellets Pharma Ltd. 
(Hyderabad, India), and E. scandens seeds were procured from the local 
market (Kurnool, Andhra Pradesh, India).
Extraction of starch from E. scandens seeds
E. scandens seed starch was isolated using aqueous and alkali extraction 
methods [8]. 5 g E. scandens seed flour was added into 100 ml distilled 
water and 0.1%, 0.25%, and 0.5% sodium hydroxide solutions 
separately, soaked (6 h and 8 h) at room temperature, and then stirred 
constantly. The slurry was filtered through 212 mesh stainless sieve 
and remaining sediment was washed with distilled water for 3 times. 
The filtrates were combined and precipitated overnight at 4°C. The 
supernatant was discarded, and the crude starch was cleaned with 
distilled water. This step was repeated 3 times, and starch cake was 
dried at 40°C for 24 h in oven dryer. The starch was ground with a 
mortar and pestle. The starches were packed in a plastic bag and kept 
at room temperature until further use.
Phytochemical tests for E. scandens seed powder and extracted 
starches
The raw E. scandens seed powder and starches extracted were subjected 
to various phytochemical tests for the identification of carbohydrates, 
proteins, alkaloids, glycosides, steroids, flavonoids, and saponins [9]. 
These results are indicated in Table 1.
Evaluation of physicochemical properties of E. scandens seed 
powder and extracted starches
Various physicochemical properties were evaluated using suitable 
methods [9]. The results are indicated in Table 2.
Gelatinization temperature
Samples of starch powder were moistened with water and loaded into 
capillary tube by means of intrusion. The temperature of gelling and the 
time from swelling to full gelatinization were measured with a melting 
point apparatus.
Determination of pH
The pH values of 1% solutions were measured using a digital pH meter.
Viscosity
Flow property of a simple liquid is expressed in terms of viscosity. 
Viscosity is an index of resistance of a liquid to flow. The higher the 
viscosity of a liquid, the greater is the resistance to flow. The viscosity 
was measured using a Brookfield Viscometer.
Swelling index
About 1 g of powdered mucilage was treated with 25 ml of water in a 
graduated cylinder shaken for every 10 min for 1 h and allowed to stand 
as specified.
Swelling Index =
Weight of wet mass
Weight of dry powder
*100
Water absorption index
1 g of sample was suspended in 10 ml of distilled water at 30°C in a 
centrifuge tube, stirred for 30 min intermittently, and then centrifuged 
at 3000 rpm for 10 min. The supernatant was decanted, and the weight 
of the gel formed was recorded. The water absorption index was then 
calculated as gel weight per gram dry sample.
Water absorption index=
Boundwater (g)
Weight of sample g( )
*100
Total microbial load of isolated E. scandens starch
The total microbial load is an important parameter which decides the 
suitability of a substance for use as an excipient in pharmaceutical 
dosage form. The starch powders were subjected to dry heat 
sterilization at 180°C for 30 min. Then, the starches were inoculated on 
medium and incubated for 24 h. Then, the colonies were counted using 
a microbial colony counter.
Preparation of telmisartan solid dispersions by fusion method 
(TP1 to TP7)
Poloxamer-188 was placed in China dish and heated at 40°C until it gets 
melted and then telmisartan was added to it. After vigorous stirring in 
normal temperature, the mixture was solidified. The solid mass was 
crushed, pulverized, and sieved. The granules obtained were stored 
in desiccators for further studies. Different formulations with various 
drug-to-polymer ratios are placed in Table 3.
Preparation of telmisartan solid dispersions by fusion method 
(TPS1 to TPS7)
After performing dissolution studies for the formulations TP1 to TP7, 
the formulation showing best dissolution profile was selected. To that 
Table 1: Phytochemical screening of Entada scandens seed 
powder and starches
Test ESSP ESS1 ESS2 ESS3 ESS4
Carbohydrates + + + + +
Polysaccharides + + + + +
Proteins + – – – –
Alkaloids + – – – –
Glycosides – – – – –
Steroids + – – – –
Flavonoids + – – – –
Saponins + – – – –
+ indicates present; – indicates absent
Table 2: Physicochemical properties of Entada scandens seed powder and extracted starches
Properties ESSP ESS1 ESS2 ESS3 ESS4
Gelatinization temperature (°C) 118–121 120–123 122–126 124–127 126–129
pH 6.32 6.50 6.62 6.78 6.98
Viscosity (cps) 1.856 2.089 2.166 2.265 2.312
Swelling index 58 63 74 76 78
Water absorption index Less More More More More
Total microbial load Absent Absent Absent Absent Absent
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formulation, E. scandens seed starch (ESS4) was added in increasing 
concentrations, i.e., 2.0, 2.5, 5.0, 7.5, 10.0, and 12.5. The optimized 
formulation was kept constant in all these formulations. ESS4 was 
placed in China dish and heated at 40°C until it gets melted and then 
optimized telmisartan solid dispersion was added to it. After vigorous 
stirring in normal temperature, the mixture was solidified. The solid 
mass was crushed, pulverized, and sieved. The granules obtained were 
stored in desiccators for further studies. Different formulations with 
various solid dispersion-to-starch percentage ratio are placed in Table 4.
Evaluation of pre-formulation parameters
The prepared solid dispersions were evaluated for various pre-
formulation parameters such as angle of repose, Carr’s index, and 
Hausner’s ratio [10]. These results are given in Table 5.
Angle of repose
The powder flow properties were determined to know the good or 
bad material flow by conducting this process in which powder was 
allowed to flow through a funnel to form a heap. Below the funnel tip, 
a graph paper was placed and the radius and heights of the heap were 
measured. The angle of repose was calculated by using the formula:




A simple test was used to evaluate the flowability of a powder by 
comparing the poured density and the tapped density of a powder and 








Hausner’s ratio is an indirect index of the ease of powder flow. It is 





Lower Hausner’s ratio (<1.25) indicates better flow properties than 
higher ones (>1.25).
Drug content uniformity for solid dispersions
Solid dispersions of telmisartan were taken and transferred into 
a 100 ml volumetric flask, and 40 ml of methanol was added to it. It 
was shaken occasionally for about 30 min, and then, it was filtered 
using Whatman filter paper. From filtrate, 10 ml was taken into and 
transferred to a 100 ml volumetric flask, and the volume was made up 
to 100 ml by adding 7.5 pH phosphate buffer with 0.5 % sodium lauryl 
sulfate. About 10 ml of the solution from the volumetric flask was taken 
and centrifuged. Then, the filtrate was subsequently diluted and the 
absorbance was measured at 295 nm. This test was repeated 6 times 
(N=6) for each formulation.
In vitro dissolution studies of telmisartan solid dispersions
Dissolution studies for each formulation were performed in a 
calibrated 8 station dissolution test apparatus (LABINDIA DS8000) 
equipped with paddles (USP apparatus II method) employing 
900 ml of phosphate buffer pH 7.5 with sodium lauryl sulfate as a 
dissolution medium. The paddles were operated at 50 rpm, and the 
temperature was maintained at 37±1°C throughout the experiment. 
The samples were withdrawn at 5, 10, 15, 20, 30, 45, 60, 75, and 
90 min and replaced with equal volume of same dissolution medium 
to maintain the constant volume throughout the experiment. Samples 
withdrawn at various time intervals were suitably diluted with the 
same dissolution medium, and the amount of the drug dissolved 
was estimated by LabIndia double beam U.V spectrophotometer (UV 
3000+) at 295 nm. The dissolution studies on each formulation were 
conducted in triplicate. The dissolution profiles for all formulations are 
given in Tables 6 and 7.
Statistical analysis
The results obtained were statistically evaluated. As the procedures 
performed and the results obtained were in triplicate, the mean along 
with their standard deviations was calculated for drug content, and 
standard error of mean was calculated for drug dissolution profiles.
Characterization studies
Based on the dissolution studies, the optimized formulations were 
selected, and Fourier transfer infrared (FTIR) and differential scanning 
calorimetry (DSC) studies were performed to observe the drug-
polymer interactions. X-ray diffraction (XRD) studies were performed 
to detect the nature of formulations. Scanning electron microscopy 
(SEM) analysis was performed on ESS4, telmisartan, poloxamer-188, 
and optimized solid dispersions TP7 and TPS7 to know surface 
characteristics. The results are shown in Figs. 1-4.
RESULTS AND DISCUSSION
Extraction of starch from E. scandens seeds
The starches extracted from E. scandens seeds were crisp slightly 
granular, free-flowing, and stable in nature. The starch extracted using 
water is given as ESS1. Similarly, the starch extracted using 0.1%, 
0.25%, and 0.5% of sodium hydroxide was labeled as ESS2, ESS3, and 
ESS4, respectively.
Phytochemical screening of E. scandens seed flour and starch 
extracts
The raw E. scandens powder and starches extracted were screened 
for the presence of various phytochemical constituents. Seed powder 
showed the presence of all components except glycosides. The starches 
extracted showed only the presence of polysaccharides which shows 
that they does not contain any other phytochemicals that interfere with 
the results. The results are indicated in Table 1.
Table 3: Composition of telmisartan solid dispersions prepared by fusion method using poloxamer-188
Formulation Composition Drug: polymer ratio (telmisartan: poloxamer-188)
TP1 Telmisartan: Poloxamer-188 1:0.5
TP2 Telmisartan: Poloxamer-188 1:1.0
TP3 Telmisartan: Poloxamer-188 1:1.5
TP4 Telmisartan: Poloxamer-188 1:2.0
TP5 Telmisartan: Poloxamer-188 1:2.5
TP6 Telmisartan: Poloxamer-188 1:3.0
TP7 Telmisartan: Poloxamer-188 1:4.0
Table 4: Composition of telmisartan solid dispersions prepared 
by fusion method using TP7 and Entada scandens seed 
starch (ESS4)
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Physicochemical parameters of E. scandens seed flour and starch 
extracts
Various physicochemical parameters were evaluated for the extracted 
starches, and the results are indicated in Table 2. The ESS4 starch was 
considered as the best suitable for formulations because it showed a 
pH nearer to body fluids, better viscosity, moderate swelling index, 
and more water absorption index. This gives the functional property of 
starch as polymer [11].
Preparation of telmisartan solid dispersions by fusion method
Solid dispersions, TP1–TP7, were prepared by fusion method using 
Poloxamer-188 as carrier in different ratios keeping telmisartan 
constant. TD indicates telmisartan pure drug. Different formulations 
with a various drug to polymer ratios are placed in Table 3.
Similarly, solid dispersions, TPS1–TPS7, were prepared by fusion 
method using E. scandens seed starch (ESS4) as superdisintegrant 
in different ratios along with constant amounts of TP7. Different 
formulations with various drug to polymer ratios are placed in Table 4.
Evaluation of pre-formulation parameters
The pre-formulation parameter values obtained for various telmisartan 
solid dispersions were in the range of good flow characteristics and are 
given in the Table 4. All the prepared granules were found to be stable 
and suitable for further studies.
In vitro dissolution studies of telmisartan solid dispersions
Dissolution studies were carried on all solid dispersions using USP 
paddle method (apparatus II) with phosphate buffer pH 7.5 with 0.5% 
SLS as dissolution medium by maintaining the bath temperature at 
37±1°C while the paddles were operated at 50 rpm. The dissolution 
profiles of all solid dispersions are given in Tables 6 and 7. The pure 
drug formulation, TM (pure drug) without any polymer, showed the 
lowest drug release in 90 min, whereas the solid dispersion, TP7, 
prepared by fusion method exhibited maximum drug release. The solid 
dispersions prepared by fusion method has enhanced the dissolution 
Table 5: Pre-formulation parameters of telmisartan solid dispersions prepared by fusion method
S. No Formulation Angle of repose (°) Carr’s index (%) Hausner’s ratio Drug content (mean±SD)
1 TD 33 20 1.22 -
2 TP1 26 18 1.19 16.85±0.45
3 TP2 25 17 1.18 17.22±0.54
4 TP3 23 17 1.18 17.85±0.41
5 TP4 23 15 1.17 18.12±0.77
6 TP5 22 13 1.16 17.54±0.81
7 TP6 22 14 1.15 17.87±0.59
8 TP7 21 13 1.15 18.81±0.17
9 TPS1 27 17 1.19 17.21±0.87
10 TPS2 26 16 1.18 17.89±0.41
11 TPS3 25 16 1.17 17.11±0.13
12 TPS4 25 15 1.17 18.04±0.81
13 TPS5 22 13 1.16 18.45±0.66
14 TPS6 21 12 1.15 18.55±0.25
15 TPS7 20 12 1.14 18.97±0.77
n=6, SD: Standard deviation
Table 6: Dissolution profiles of telmisartan solid dispersions prepared by fusion method (TP1–TP7)
Time (min) Cumulative % drug released (mean±SEM)
TD TP1 TP2 TP3 TP4 TP5 TP6 TP7
5 26.20±1.12 27.44±1.25 30.08±0.43 35.44±0.57 43.34±1.95 46.84±0.43 51.48±1.27 58.86±0.64
10 30.90±0.89 31.79±0.47 34.63±1.22 39.22±1.83 46.07±0.41 49.55±1.66 54.29±0.53 88.87±1.52
15 34.74±1.51 35.42±1.93 39.60±0.86 43.54±1.40 49.78±1.87 52.98±1.78 58.51±1.82 96.50±0.84
20 36.68±0.64 39.62±0.55 42.99±1.10 46.48±0.07 52.58±0.62 56.01±0.91 62.43±2.31 96.17±2.14
30 38.82±1.22 42.96±1.82 46.87±0.46 49.68±2.82 55.33±2.44 59.51±2.25 65.04±0.95 96.37±1.49
45 39.44±0.87 45.61±1.34 50.81±1.38 53.61±1.48 58.97±0.89 62.11±1.66 68.73±1.46 96.76±2.41
60 40.65±1.31 48.93±0.61 56.22±0.29 58.82±1.75 62.12±1.54 65.98±0.63 71.45±0.88 97.12±0.1.75
75 41.87±1.56 52.51±0.39 61.57±1.83 62.77±1.11 65.31±1.43 68.41±1.49 75.01±1.57 98.09±0.68
90 42.68±0.91 55.57±1.22 65.62±0.87 66.34±0.67 68.94±1.27 71.88±1.19 79.17±1.61 98.14±1.43
n=3, SEM: Standard error of mean
Table 7: Dissolution profiles of telmisartan solid dispersions prepared by fusion method (TPS1–TPS7)
Time (min) Cumulative % drug released (mean±SEM)
TP7 TPS1 TPS2 TPS3 TPS4 TPS5 TPS6 TPS7
5 58.86±0.64 66.15±2.24 66.46±1.65 68.2±1.22 70.49±1.58 74.86±1.08 80.13±0.89 84.52±1.07
10 88.87±1.52 87.34±1.13 88.39±1.89 89.42±1.35 90.13±1.05 94.16±1.55 96.16±1.19 97.76±1.83
15 96.50±0.84 98.04±1.65 98.12±1.22 98.24±0.84 98.29±1.69 98.36±1.94 98.41±1.64 98.98±0.99
20 96.17±2.14 98.14±1.98 98.22±1.05 98.28±0.93 98.34±2.05 98.41±2.44 98.52±1.83 99.01±1.55
30 96.37±1.49 98.21±1.05 98.34±2.06 98.39±1.54 98.41±0.76 98.45±2.31 98.60±1.94 99.12±0.72
45 96.76±2.41 98.24±0.99 98.42±1.84 98.46±1.62 98.49±1.39 98.54±1.65 98.74±2.16 99.24±1.85
60 97.12±0.1.75 98.32±0.87 98.46±0.91 98.52±2.46 98.56±1.60 98.62±1.89 98.81±2.58 99.31±2.23
75 98.09±0.68 98.35±1.24 98.51±1.32 98.59±2.11 98.61±0.88 98.68±0.84 98.86±1.07 99.40±1.94
90 98.14±1.43 98.44±1.85 98.56±1.77 98.63±1.47 98.68±2.65 98.74±1.08 98.92±1.66 99.44±1.84
n=3, SEM: Standard error of mean
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rate which might be due to molecular inclusion of drug molecules into a 
long chain polymeric material containing hydrophobic and hydrophilic 
moieties [12,13]. It was also observed that as the concentration of 
poloxamer increased, the rate of dissolution of solid dispersions was 
also greatly increased. Past studies also revealed that fusion method is 
best to enhance the dissolution rate of poorly soluble drugs [14]. The 
dissolution profiles are indicated in Table 6.
Similarly, the dissolution studies were also carried out for the solid 
dispersions prepared using TP7 mixed with E. scandens seed starch 
(ESS4) to determine the carrier effect of starch. Invitro dissolution 
studies revealed that the formulation TPS7 prepared with 15% of Entada 
scandens seed starch showed more drug release in less time. This indicates 
the superdisintegrant effect of starch. This strongly coincides with the 
recent studies with regard to the application of natural starches as 
superdisintegrants [15]. The dissolution profiles are indicated in Table 7.
Characterization of telmisartan solid dispersions
FTIR spectral analysis
The FTIR spectral investigations were carried out on pure drug 
of telmisartan, poloxamer-188, ESS4, and solid dispersions of 
telmisartan TP7 and TPS7. Telmisartan pure drug showed a broad 
peak at 3143.31/cm and sharp peaks at 2868.59/cm, 1100.64/cm, and 
862.64/cm indicating the presence of NH/OH stretching, CH stretching, 
C-N/C-O-C cyclic ether stretching, and aromatic CH stretching. For 
poloxamer, a broad peak at 3499.85/cm and sharp peaks at 2880.40/cm, 
1103.79/cmand 842.24/cm indicate NH/OH stretching, CH stretching, 
C-N/C-O-C cyclic ether stretching, and aromatic CH stretching. Starch 
extracted from E. scandens, ESS4, exhibited sharp peaks at 3049.42/
cm, 1645.74/cm, 1242.69/cm,and 1014.79/cm indicating the presence 
of ≡C-H stretching, C=O stretching, C=C stretching, and ≡C-O- stretching. 
The solid dispersions TP7 and TPS7 showed a slight reduced intensity 
compared to that of drug and polymers, indicating that there were no 
drug-excipient interactions [16]. The detailed spectral elucidations 
were shown in Fig. 1.
DSC thermogram analysis
The DSC thermographic studies were carried out on pure drug of 
telmisartan, Poloxamer-188, ESS4, and solid dispersions of telmisartan 
TP7 and TPS7.
These studies exhibited broad endothermic peak at 278.96° for 
telmisartan pure drug, a sharp endothermic peak at 59.51°C for 
Poloxamer-188, a broad endothermic peak at 311.1°C for ESS4, a 
broad endothermic peak at 268.43°C, and a sharp endothermic peak 
at 59.48°C for TP7 formulation, indicating that there is a slight shift in 
temperature for drug. A sharp endothermic peak at 57.47°C and broad 
endothermic peaks at 283.24°C and 332.95°C for formulation TPS7 
were observed, indicating that there is a slight shift in temperature 
for drug and starch. On the basis of this thermal behavior, drug and 
excipients used in this study were found to be compatible with each 
other. The detailed thermographs are shown in Fig. 2.
SEM analysis
SEM images were taken for pure drug telmisartan, poloxamer-188, ESS4, 
and solid dispersions TP7 and TPS7. Telmisartan pure drug exhibited 
crystalline form. Poloxamer-188 exhibited free-flowing large spherical 
forms. The ESS4 starch exhibited free-flowing spherical low dense form 
of starch grains without any mucilage/resinous coverage. The SEM 
image of TP7 solid dispersion clearly exhibited uniform dispersion of 
drug with poloxamer-188. The SEM image of TPS7 solid dispersion 
clearly exhibited uniform dispersion of drug with poloxamer-188 and 
starch grains. The obtained results could be attributed to the dispersion 
of drug in the molten mass of polymer [17]. The detailed SEM images 
are shown in Fig. 3.
XRD analysis
XRD diffraction studies were carried out for pure drug telmisartan, 
poloxamer-188, ESS4, and solid dispersions TP7 and TPS7.
The XRD of telmisartan showed its typical crystalline pattern. 
Poloxamer-188 showed crystalline nature. ESS4 showed amorphous 
nature. Formulation, TP7 which is a solid dispersion made of telmisartan 
and poloxamer-188, showed diffused peaks indicating the amorphous 
nature of the solid dispersions. Formulation, TPS7 which is a mixture of 
TP7 solid dispersions and 15% of ESS4 starch, showed diffused peaks 
indicating the amorphous nature of the solid dispersions. These results 
indicated that the drug was bound well with the polymers used which 
were indicated by the change in phase [18]. The detailed diffractograms 
are shown in Fig. 4. Several studies conducted in the past also revealed 
that solid dispersion forms enhanced the solubility of poorly water-
soluble drugs [19].
CONCLUSION
The starch ESS4, extracted from E. scandens seeds by 0.5% sodium 
hydroxide, is found to be the best and is used as superdisintegrant for 
the preparation of solid dispersions. Telmisartan solid dispersions were 
prepared using various concentrations of ESS4 and Poloxamer-188 
and were subjected to in vitro dissolution studies. From these studies, 
it was observed that the proportion of starch as superdisintegrant has 
Fig. 1: Fourier transfer infrared spectra: (a) Telmisartan (b) Poloxamer-188 (c) ESS4 (d) TP7 (e) TPS7; ESS4: Entada scandens seed starch 
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influenced the dissolution parameters of various formulations. Higher 
dissolution rate was observed for formulation, TPS7 containing 15% w/w 
of ESS4 as superdisintegrant mixed with the solid dispersion TP7. The 
possible mechanism of superdisintegrant effect of these starches might be 
the rapid uptake of water, followed by swelling which causes the elevation 
of hydrostatic pressure that leads to faster dispersion. The optimized 
formulations were subjected to FTIR and DSC analysis to study the drug-
excipient interactions, which revealed no such interactions. Similarly, XRD 
Fig. 2: Differential scanning calorimetry thermograms: (a) Telmisartan, (b) poloxamer-188, (c) ESS4, (d) TP7 (e) TPS7; ESS4: Entada 
scandens seed starch extracted by 0.5 % sodium hydroxide; TP7: Solid dispersion of telmisartan+Poloxamer-188 in 1:4 ratios; TPS7: Solid 




Fig. 3: Scanning electron microscopy images: (a) Telmisartan, (b) poloxamer-188, (c) ESS4, (d) TP7, (e) TPS7; ESS4: Entada scandens seed 
starch extracted by 0.5% sodium hydroxide; TP7: Solid dispersion of telmisartan+poloxamer-188 in 1:4 ratios; TPS7: Solid dispersion of 
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studies were conducted to know the crystalline and amorphous nature 
of the samples. Based on the above studies, it may be concluded that the 
telmisartan solid dispersions prepared using 0.5% sodium hydroxide 
extracted E. scandens seed starch showed rapid drug release.
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